Motus GI Holdings Inc (NASDAQ:MOTS) Director Gary E. Jacobs purchased 7,100 shares of the company’s stock in a transaction on Tuesday, November 27th. The stock was bought at an average price of $3.48 per share, for a total transaction of $24,708.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of MOTS opened at $3.39 on Friday. The company has a market cap of $51.62 million and a PE ratio of -2.65. Motus GI Holdings Inc has a 12-month low of $3.03 and a 12-month high of $10.66.

Motus GI (NASDAQ:MOTS) last issued its quarterly earnings results on Wednesday, November 14th. The company reported ($0.33) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.27) by ($0.06). As a group, research analysts predict that Motus GI Holdings Inc will post -1.08 EPS for the current year.

Several hedge funds and other institutional investors have recently modified their holdings of MOTS. Lombard Odier Asset Management USA Corp lifted its holdings in shares of Motus GI by 78.6% during the third quarter. Lombard Odier Asset Management USA Corp now owns 125,000 shares of the company’s stock worth $638,000 after purchasing an additional 55,000 shares during the period. Eaton Vance Management acquired a new stake in shares of Motus GI during the third quarter worth $204,000. Renaissance Technologies LLC acquired a new stake in shares of Motus GI during the third quarter worth $139,000. Private Advisor Group LLC acquired a new stake in shares of Motus GI during the third quarter worth $105,000. Finally, Quantitative Systematic Strategies LLC acquired a new stake in shares of Motus GI during the second quarter worth $113,000. 22.27% of the stock is owned by hedge funds and other institutional investors.

A number of equities analysts have recently issued reports on the stock. LADENBURG THALM/SH SH assumed coverage on shares of Motus GI in a research report on Thursday, August 30th. They set a “buy” rating and a $14.50 target price on the stock. Zacks Investment Research upgraded shares of Motus GI from a “sell” rating to a “hold” rating in a research report on Saturday, August 18th. Dougherty & Co assumed coverage on shares of Motus GI in a research report on Tuesday, August 28th. They set a “buy” rating and a $8.00 target price on the stock. Finally, Oppenheimer restated a “buy” rating on shares of Motus GI in a research report on Tuesday, September 25th. One research analyst has rated the stock with a sell rating and six have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $10.50.

ILLEGAL ACTIVITY WARNING: “Gary E. Jacobs Buys 7,100 Shares of Motus GI Holdings Inc (NASDAQ:MOTS) Stock” was first published by Marea Informative and is the property of of Marea Informative. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.mareainformativa.com/news/2018/12/15/gary-e-jacobs-purchases-7100-shares-of-motus-gi-holdings-inc-mots-stock-updated-updated.html.

Motus GI Company Profile

Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

Featured Story: What is systematic risk?

Insider Buying and Selling by Quarter for Motus GI (NASDAQ:MOTS)

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.